Form 4: Intuitive Surgical Executive Stock Sale

Gary Loeb, EVP & Chief Legal and Compliance Officer at Intuitive Surgical, sold 400 shares of common stock.

Summary

• Gary Loeb, EVP & Chief Legal and Compliance Officer of Intuitive Surgical, Inc. (ISRG), sold 400 shares of common stock.
• The transaction occurred on May 11, 2026, at a price of $446.95 per share.
• Following this transaction, the reporting person retains beneficial ownership of 6,120 shares.
• The sale was executed under a pre-established Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed via a pre-planned 10b5-1 program, which is standard practice for executive financial planning.

Positives

• The transaction was conducted under a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.

Negatives

• The sale represents a reduction in the executive's direct equity stake in the company.

Risks

• None identified; this is a routine disclosure of an executive stock sale.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that routine insider selling under 10b5-1 plans is common practice among senior executives at large-cap medical technology firms and generally does not signal a change in corporate strategy or outlook.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives at companies like Medtronic, Stryker, and Edwards Lifesciences to manage personal liquidity.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and represents a small portion of the executive's total holdings.

Key Dates

Keywords

Intuitive Surgical, ISRG, Insider Trading, Form 4, Executive Stock Sale, Rule 10b5-1